Document and Entity Information
Document and Entity Information | May 20, 2021 |
Document and Entity Information [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 20, 2021 |
Entity File Number | 001-40315 |
Entity Registrant Name | Reneo Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-2309515 |
Entity Address, Address Line One | 12230 El Camino Real |
Entity Address, Adress Line Two | Suite 230 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92130 |
City Area Code | 858 |
Local Phone Number | 283-0280 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.0001 per share |
Trading Symbol | RPHM |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001637715 |
Amendment Flag | false |